Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Chen P, Söderdahl G, Österborg A, Smith CIE, Wullimann D, Vesterbacka J, Lindgren G, Blixt L, Friman G, Wahren-Borgström E, Nordlander A, Gomez AC, Akber M, Valentini D, Norlin AC, Thalme A, Bogdanovic G, Muschiol S, Nilsson P, Hober S, Loré K, Chen MS, Buggert M, Ljunggren HG, Ljungman P, Aleman S; COVAXID-collaborator group (shown separately). Bergman P, et al. Among authors: ljungman p. EBioMedicine. 2021 Dec;74:103705. doi: 10.1016/j.ebiom.2021.103705. Epub 2021 Nov 30. EBioMedicine. 2021. PMID: 34861491 Free PMC article. Clinical Trial.
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A, Mattsson J, Ringdén O, Leblanc K, Gustafsson B, Ljungman P, Svenberg P, Svennilson J, Remberger M. Nordlander A, et al. Among authors: ljungman p. Biol Blood Marrow Transplant. 2004 Mar;10(3):195-203. doi: 10.1016/j.bbmt.2003.11.002. Biol Blood Marrow Transplant. 2004. PMID: 14993885 Free article.
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study.
Remberger M, Ackefors M, Berglund S, Blennow O, Dahllöf G, Dlugosz A, Garming-Legert K, Gertow J, Gustafsson B, Hassan M, Hassan Z, Hauzenberger D, Hägglund H, Karlsson H, Klingspor L, Kumlien G, Le Blanc K, Ljungman P, Machaczka M, Malmberg KJ, Marschall HU, Mattsson J, Olsson R, Omazic B, Sairafi D, Schaffer M, Svahn BM, Svenberg P, Swartling L, Szakos A, Uhlin M, Uzunel M, Watz E, Wernerson A, Wikman A, Wikström AC, Winiarski J, Ringdén O. Remberger M, et al. Among authors: ljungman p. Biol Blood Marrow Transplant. 2011 Nov;17(11):1688-97. doi: 10.1016/j.bbmt.2011.05.001. Epub 2011 May 11. Biol Blood Marrow Transplant. 2011. PMID: 21620989 Free article.
Vaccination of immunocompromised patients.
Ljungman P. Ljungman P. Clin Microbiol Infect. 2012 Oct;18 Suppl 5:93-9. doi: 10.1111/j.1469-0691.2012.03971.x. Clin Microbiol Infect. 2012. PMID: 23051059 Free article. Review.
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Uhlin M, Wikell H, Sundin M, Blennow O, Maeurer M, Ringden O, Winiarski J, Ljungman P, Remberger M, Mattsson J. Uhlin M, et al. Among authors: ljungman p. Haematologica. 2014 Feb;99(2):346-52. doi: 10.3324/haematol.2013.087338. Epub 2013 Sep 20. Haematologica. 2014. PMID: 24056821 Free PMC article. Clinical Trial.
743 results